来自MSN4 分钟
Research finds no change in mortality despite platinum chemotherapy shortage
During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no ...
Chemotherapy shortage did not increase cancer patient mortality
During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no ...
Science Daily23 小时
Generic platinum chemotherapy shortages did not increase deaths
An analysis of national data found that short-term mortality was not impacted for patients with advanced cancers during the shortage of the generic platinum chemotherapy drugs cisplatin and ...
Medindia5 小时
Platinum Chemotherapy Drugs' Shortages and Cancer Mortality
Because cisplatin and carboplatin were prioritized for patients with curable cancers during the shortage, the researchers ...
News Medical on MSN4 天
Metabolic imaging detects ovarian cancer subtypes and predicts chemotherapy response
Study demonstrates how metabolic imaging differentiates high and low oxidative phosphorylation (OXPHOS) subtypes of ...
News Medical on MSN6 天
MRI-based imaging technique predicts the response of ovarian cancer to treatment
An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumors to ...
New scan could provide rapid feedback on cancer treatment success
Scientists have developed a new type of scan which could rapidly reveal which treatments work best for ovarian cancer ...
The Pharma Letter2 天
China “Breakthrough” status for Hutchmed’s Orpathys and Tagrisso combo
Chinese biopharma Hutchmed today announced that the Center for Drug Evaluation of China’s National Medical Products ...
来自MSN1 天
Inupadenant “deprioritised” by iTeos in favour of pipeline TIGIT therapy
Teos' Phase II trial for inupadenant met its primary and secondary endpoints but offered little more than existing treatments ...